Dr. Stephen Matta, DO, MBA, CAQSM, is a triple board-certified physician in Family Medicine, Sports Medicine, and Stem Cell Therapy. He is co-founder of Meeting Point Health in Philadelphia. Specializing in regenerative orthopedics, anti-aging, and cellular medicine, he integrates holistic therapies like ultrasound-guided regenerative injections with orthobiologics, osteopathic manipulation, peptide and hormone therapy, and medical acupuncture to address chronic pain and nervous system dysregulation. A graduate of Philadelphia College of Osteopathic Medicine, Dr. Matta completed his residency at Valley Baptist Family Practice in Texas, and a fellowship in Primary Care Sports Medicine at Mountainside Sports Medicine in New Jersey. His East-meets-West approach, co-developed with his wife, Mary Anne Matta, emphasizes root-cause solutions, utilizing peptides, ozone therapy, and stem cell therapy. Formerly a team physician for the Antigua Professional Soccer Team and NJIT Division I sports, Dr. Matta is a Fellow of the SSRP Institute and a sought-after speaker. His comprehensive assessments and patient-centered care have transformed lives, earning him a reputation as a master diagnostician dedicated to unlocking human potential through integrative medicine.
Article
Dec 10, 2025
Stephen Matta, DO, MBA, CAQSM
Myriah Werne
RELATED RESOURCES
Continue exploring related topics.
VIEW ALL
William Seeds, MD
Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
Introduction In March of this year, I did a Rabbit Hole (Episode 079) in which I discussed a number of trends marketed to the wider public promising sleep improvement. As you know, a huge swath of the population suffers from sleep disturbance. According to the NIH, approximately 30% to 40% of US adults report sleep […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Apr 20, 2026
Ep. 084 - The Cellular Impact of UVA vs. UVB Light (Part 2)
Preview Only
Rabbit Holes – Episode 084
The Cellular Impact of UVA vs. UVB Light (Part 2)
Dr. Seeds continues this Rabbit Hole on UVA vs. UVB light in Part 2, covering oxidative stress, skin aging, vitamin D synthesis, and the risks of tanning beds. A helpful look at why not all UV exposure works the same, why that distinction matters, and how it shapes both skin health and cellular function
Catch Part 1 (Rabbit Holes – Ep. 081) HERE
Preview Only — Become a member for full access
SSRP Institute
Apr 15, 2026
FDA Announces Change in Status of 12 Peptides
BREAKING NEWS APRIL 15, 2026 – In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500. Originally nominated for Category 2 (Bulk Substances that […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 13, 2026
Ep. 083 - Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients
Preview Only
Journal Club – Episode 083
Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients
Dr. Seeds discusses this article on low dose minoxidil for hair loss and shares why a lower, slower dosing approach may lead to better outcomes. He also reviews key safety considerations, side effects, and practical dosing insights for both men and women. (Article Link)
Preview Only — Become a member for full access
SSRP Institute
Apr 9, 2026
SSRP Institute Welcomes StemWave as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [April 9, 2026] — The SSRP Institute announces that StemWave has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. StemWave provides an FDA-listed, non-invasive acoustic wave therapy platform used in musculoskeletal care. The technology delivers focused mechanical energy to targeted tissues, supporting improved circulation, […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 6, 2026
Ep. 082 - April '26
Preview Only
Dr. Seeds’ Office Hours – Episode 082
1. Idiopathic pulmonary fibrosis in patient already receiving immunosuppressive therapy (1:01)
2. Peptide considerations for a 14-year-old diagnosed with “internal preoccupation” (28:44)
3. Patient with hypermobility, mitochondrial dysfunction, and mast cell activation after COVID (39:48)
Preview Only — Become a member for full access
Mastermind
Mastermind
Mastermind 15: The Aesthetic Matrix
This course teaches a mechanism-informed approach to aesthetic skin aging by connecting environmental exposures and procedures with cellular stress, inflammation, and repair biology. You’ll review how UVA and UVB contribute to photoaging, how visible/blue light is discussed in pigmentation and...
10 Lessons
17 hrs 24 min
VIDEO
Cellular Medicine Mondays
Mar 30, 2026
Ep. 081 - The Cellular Impact of UVA vs. UVB Light (Part 1)
Preview Only
Rabbit Holes – Episode 081
The Cellular Impact of UVA vs. UVB Light (Part 1)
In this Rabbit Holes episode, Dr. Seeds explains the mechanistic differences between UVA and UVB light, highlighting how each spectrum uniquely contributes to photoaging, oxidative stress, DNA damage, and skin cancer risk. He also outlines cellular strategies to support antioxidant defenses, mitochondrial function, and DNA repair in response to chronic light exposure.
Want to learn more? Check out Mastermind 15 on Aesthetics!
Preview Only — Become a member for full access
Medivive
Mar 27, 2026
SSRP Institute Welcomes Medivive as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [March 27, 2026] — The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP’s mission of advancing science-first, education-driven clinical collaboration. Medivive offers an advanced approach to NAD⁺ therapy designed to support cellular energetics through sterile, clinician-prescribed formulations […]
READ NEWS
William Seeds, MD
Mar 25, 2026
The Truth about Ketone Esters: Not All Exogenous Products are the Same
The Father of Ketones and the Value of Exogenous Ketone Esters I’ve talked about ketones and ketone esters for many years, and I’ve now come to a place where I really have to take a more direct stand on how they’ve been marketed to the wider public, and in particular, to providers who may not […]
READ ARTICLE